임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
60건 표시 (상위 60건)
- 1상모집 예정· Healthy SubjectsBioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects
리드: 유한양행
- 1상모집 중· Healthy SubjectsBioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
리드: 유한양행
- 1상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM)Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
리드: 셀트리온
- 1상모집 중· Advanced Solid TumorsA Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
리드: 삼성바이오에피스
- 1상모집 예정· Benign Prostate Hypertrophy(BPH)A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
리드: 종근당
- 1상완료· Healthy Male SubjectsA Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects
리드: 셀트리온
- 1상완료· Healthy SubjectsPK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
리드: 대웅제약
- 1상모집 중· Advanced Solid TumorsPhase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors
리드: 종근당
- 1상모집 중단 (진행 중)· Healthy ParticipantsStudy to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
리드: 셀트리온
- 1상모집 중· Healthy SubjectsPK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
리드: 대웅제약
- 1상완료· Healthy Male AdultsTo Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
리드: JW중외제약
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers
리드: 셀트리온
- 1상완료· Healthy Male SubjectsA Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects
리드: 셀트리온
- 1상완료· Healthy VolunteersBioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers
리드: 유한양행
- 1상모집 중· Advanced or Metastatic Solid TumorsDose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
- 1상모집 중· Sanfilippo Syndrome Type APhase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
리드: GC녹십자
- 1상완료· Healthy SubjectsA Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants
리드: 종근당
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
리드: 종근당
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
리드: 종근당
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
리드: 종근당
- 1상완료· Healthy VolunteersBioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers
리드: 유한양행
- 1상모집 예정· Healthy VolunteersBioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315
리드: 대웅제약
- 1상모집 중· Healthy ParticipantsA First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants
리드: 유한양행
- 1상모집 예정· Type 2 Diabetes MellitusTo Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
리드: 종근당
- 1상상태 미확인· Erosive Gastroesophageal Reflux Diseaseto Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
리드: 대웅제약
- 1상완료· Healthy VolunteersBioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers
리드: 유한양행
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.